Surveillance of Shiga toxigenic Escherichia coli in Australia
DOI:
https://doi.org/10.33321/cdi.2005.29.40Keywords:
Escherichia coli, Shiga toxin, diagnoses, surveillanceAbstract
All Australian States and Territories have low rates (= 0.32 cases per 100,000 population) of notification for Shiga toxin-producing Escherichia coli (STEC), except for South Australia where the rates are tenfold higher at 2.58 cases per 100,000 population. To explore possible reasons for the variation in rates we surveyed public health reference laboratories to determine the methods used and number of specimens tested for these organisms. Only five of eight jurisdictions routinely conducted testing for STEC, and polymerase chain based tests were most common. Culture was also common and in one that tests specimens with culture, approximately 1.2 per cent of specimens were positive. The notification rates for different jurisdictions reflected the number of specimens tested, with testing = 500 specimens having rates = 0.32 cases per 100,000 population. The use of culture as a test method may also influence notification rates. Public health agencies must consider the number of specimens tested in interpreting surveillance data. Commun Dis Intell 2005;29:366–369.
Downloads
References
Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983;308:681–685.
Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli 0111:NM– South Australia, 1995. MMWR Morb Mortal Wkly Rep 1995;44:550–551, 557–558.
Australian Government Department of Health and Ageing. Communicable Diseases Network Australia –National Notifiable Diseases Surveillance System. Notifications of STEC/VTEC, Australia 1996–2002. Australian Government Department of Health and Ageing. Canberra; 2003.
OzFoodNet Working Group. Foodborne disease investigation across Australia: annual report of the OzFoodNet network, 2003. Commun Dis Intell 2004;28:359–389.
OzFoodNet Working Group. Enhancing foodborne disease surveillance across Australia in 2001: the OzFoodNet Working Group. Commun Dis Intell 2002;26:375–406.
Gavin PJ, Thomson Jr RB. Diagnosis of enterohemorrhagic Escherichia coli infection by detection of Shiga toxins. Clin Micro Newsletter 2004;26:49–54.
Fey PD, Wickert RS, Rupp ME, Safranek TJ, Hinrichs SH. Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 2000;6:530–533.
Mackenzie AM, Lebel P, Orrbine E, Rowe PC, Hyde L, Chan F, et al. Sensitivities and specificities of premier E. coli O157 and premier EHEC enzyme immunoassays for diagnosis of infection with verotoxin (Shiga-like toxin)-producing Escherichia coli. The SYNSORB Pk Study investigators. J Clin Microbiol 1998;36:1608–1611.
Doyle R, Watson K, Unicomb LE, Lancer JA, Wise R, Ratcliff R, et al. Laboratory surveillance of Shiga toxin producing Escherichia coli in South Australia and the Hunter Health Area, New South Wales, Australia. Commun Dis Intell 2004;28:390–391.
Preliminary FoodNet data on the incidence of foodborne illnesses–selected sites, United States, 2000. MMWR Morb Mortal Wkly Rep 2001;50:241–246.
Chalmers RM, Parry SM, Salmon RL, Smith RM, Willshaw GA, Cheasty T. The surveillance of vero cytotoxin-producing Escherichia coli O157 in Wales, 1990 to 1998. Emerg Infect Dis 1999;5:566–569.
Downloads
Published
How to Cite
License
Copyright (c) 2005 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
